Surgical outcomes following laparoscopic adrenalectomy for treatment of Conn's syndrome (primary hyperaldosteronism) between 1999 and 2006
- PMID: 20953222
Surgical outcomes following laparoscopic adrenalectomy for treatment of Conn's syndrome (primary hyperaldosteronism) between 1999 and 2006
Abstract
Background: Primary hyperaldosteronism is a recognised cause of secondary hypertension with its aetiology most commonly due to a secreting aldosterone adenoma of the adrenal gland. Laparoscopic resection of the adrenal tumour has now become the accepted form of intervention. The aim of this study was to assess the effectiveness of such procedures performed by one surgeon over a 7-year period.
Method: An observational study was conducted in respect of 33 patients who underwent adrenalectomies for primary hyperaldosteronism between 1999-2006. Information on blood pressure, electrolytes, medications, histology, patient characteristics and patients' perception of benefit was gathered via clinical notes and a patient questionnaire.
Results: 33 patients were reviewed. The mean follow-up was 38.4 months. Blood pressure and number of medications all had statistically significant decreases. Systolic blood pressure decreased from 146 mmHg preoperatively to 130 mmHg at final follow-up (p<0.00005). Diastolic blood pressure decreased from 91.0 mmHg preoperatively to 81.5 mmHg (p<0.00005). There was also a significant decrease in number of blood pressure medications from 2.3 preoperatively to 1.0 on average (p<0.00005). Only one patient required potassium at final review. Overall 36% had clinical cure and 50% had significant improvement in terms of blood pressure and medications requirements.
Conclusion: The results suggest unilateral laparoscopic adrenalectomy is an effective tool in treatment for benign primary hyperaldosteronism caused by aldosterone secreting adenomas.
Similar articles
-
Outcomes of laparoscopic adrenalectomy for hyperaldosteronism.ANZ J Surg. 2007 Sep;77(9):768-73. doi: 10.1111/j.1445-2197.2007.04225.x. ANZ J Surg. 2007. PMID: 17685956 Clinical Trial.
-
Primary hyperaldosteronism in the era of laparoscopic adrenalectomy.Am Surg. 2002 Mar;68(3):253-6; discussion 256-7. Am Surg. 2002. PMID: 11893103
-
Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma.J Hypertens. 2008 Sep;26(9):1816-23. doi: 10.1097/HJH.0b013e3283060f0c. J Hypertens. 2008. PMID: 18698217
-
Surgical technique and haemodynamic changes in adrenalectomy for secreting neoplasia. Personal experience and review of the literature.Minerva Chir. 2003 Feb;58(1):87-92. Minerva Chir. 2003. PMID: 12692501 Review.
-
Outcomes of adrenalectomy in patients with unilateral primary aldosteronism: a review.Horm Metab Res. 2012 Mar;44(3):221-7. doi: 10.1055/s-0031-1299681. Epub 2012 Jan 13. Horm Metab Res. 2012. PMID: 22395801 Review.
Cited by
-
Short- and long-term results of laparoscopic adrenalectomy for Conn's syndrome.Wideochir Inne Tech Maloinwazyjne. 2018 Sep;13(3):292-298. doi: 10.5114/wiitm.2018.74833. Epub 2018 Apr 3. Wideochir Inne Tech Maloinwazyjne. 2018. PMID: 30302141 Free PMC article.
-
Single-incision transperitoneal laparoscopic left adrenalectomy.World J Surg. 2012 Jun;36(6):1395-9. doi: 10.1007/s00268-012-1555-7. World J Surg. 2012. PMID: 22392358 Clinical Trial.
-
Reversibility of myocardial hypertrophy 8 years after adrenal adenoma excision and drugs and alcohol addiction withdrawal.BMJ Case Rep. 2013 May 13;2013:bcr2013009738. doi: 10.1136/bcr-2013-009738. BMJ Case Rep. 2013. PMID: 23674558 Free PMC article. No abstract available.